1. Home
  2. OMDA vs RGNX Comparison

OMDA vs RGNX Comparison

Compare OMDA & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OMDA

Omada Health Inc.

HOLD

Current Price

$13.12

Market Cap

711.1M

Sector

Health Care

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$9.36

Market Cap

418.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMDA
RGNX
Founded
2011
2008
Country
United States
United States
Employees
868
N/A
Industry
Medical/Nursing Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
711.1M
418.1M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
OMDA
RGNX
Price
$13.12
$9.36
Analyst Decision
Buy
Strong Buy
Analyst Count
11
8
Target Price
$21.73
$28.75
AVG Volume (30 Days)
846.7K
572.1K
Earning Date
05-17-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.08
EPS
N/A
N/A
Revenue
N/A
$10,393,000.00
Revenue This Year
$24.94
$50.15
Revenue Next Year
$20.18
$23.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
126.48
52 Week Low
$10.28
$5.85
52 Week High
$26.92
$16.19

Technical Indicators

Market Signals
Indicator
OMDA
RGNX
Relative Strength Index (RSI) 53.72 57.67
Support Level $10.28 $7.76
Resistance Level $16.93 $10.08
Average True Range (ATR) 0.77 0.50
MACD 0.02 0.17
Stochastic Oscillator 87.23 89.45

Price Performance

Historical Comparison
OMDA
RGNX

About OMDA Omada Health Inc.

Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The Company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: